Celebrex vs Lyrica
Side-by-side cost comparison based on Medicare Part D data
Celebrex
Celecoxib
Manufactured by Pfizer
Lyrica
Pregabalin
Manufactured by Pfizer
Celebrex costs 37% less per claim than Lyrica ($53.00 vs $84.00). A generic version of Celebrex is also available, which may reduce costs further.
Cost Per Claim
Medicare Spending
Beneficiaries
Annual Cost Per Patient
Full Comparison
| Metric | Celebrex | Lyrica |
|---|---|---|
| Avg Cost Per Claim | $53.00 | $84.00 |
| Total Medicare Spending | $345.0M | $723.0M |
| Total Beneficiaries | 980,000 | 1,240,000 |
| Total Claims | 6,480,000 | 8,640,000 |
| Annual Cost/Patient | $352.00 | $583.00 |
| Year-over-Year Change | -42.1% | -42.5% |
| Generic Available | Yes | Yes |
| Patent Expiration | Jan 31, 2023 | Jan 31, 2023 |
| Manufacturer | Pfizer | Pfizer |
| Condition | Pain | Pain |
| Generic Name | Celecoxib | Pregabalin |
Celebrex vs Lyrica: What the Data Shows
Celebrex (Celecoxib) and Lyrica (Pregabalin) are both used to treat pain. Based on Medicare Part D data, Celebrex costs $53.00 per claim, which is 37% less than Lyrica at $84.00 per claim.
Medicare spent $345.0M on Celebrex and $723.0M on Lyrica. In terms of patient reach, Lyrica serves more beneficiaries (1,240,000 vs 980,000).
Year-over-year spending changed -42.1% for Celebrex and -42.5% for Lyrica.
Both drugs have generic versions available. Patients should discuss generic alternatives with their pharmacist to reduce out-of-pocket costs.
Frequently Asked Questions
Celebrex is cheaper at $53.00 per claim, compared to $84.00 for Lyrica. That makes Celebrex about 37% less expensive per claim based on Medicare Part D data.
Yes, both Celebrex and Lyrica are used to treat pain. Your doctor can help determine which medication is more appropriate for your specific situation.
Both drugs have generic versions available. Generic Celecoxib and generic Pregabalin can offer significant cost savings — typically 80-95% less than the brand name.
Medicare Part D spent $345.0M on Celebrex covering 980,000 beneficiaries, and $723.0M on Lyrica covering 1,240,000 beneficiaries.
Explore Further
Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims. This comparison is informational only and should not replace medical advice.